Aurora Spine Corporation : FIRST SURGICAL IMPLANT OF ZIP ULTRA(TM) MIS INTERSPINOUS DEVICE PERFORMED IN THE UNITED KINGDOM
Aurora Spine Corporation (TSXV:ASG) announced today the first surgical implant of the company's ZIP ULTRA(TM) Minimally Invasive Interspinous Device in the United Kingdom. The surgery was performed at the University Hospital Llandough, a part of the Cardiff and Vale University Health Board, by Mr. Stuart James.
"The ZIP MIS implant is very well designed. It is both stable and secure. Implanting the device was simple, easy and safe," said Mr. Stuart James. "I will be expanding my use of the product as I believe it has multiple spine fusion indications."
Mr. James has completed a recognized spine fellowship in Bristol, UK, where he has gained extensive experience in all aspects of spinal disease and spinal conditions. His experience ranges from trauma and tumor work through to adult and pediatric complex deformity of the spine. In addition to his spine specialist training in the UK, Mr. James has gained further exposure and training in cutting edge contemporary spinal techniques across Europe and the USA.
"We are absolutely thrilled that Aurora now offers our MIS portfolio in the United Kingdom, including the ZIP MIS Interspinous System. We believe that the ZIP device will change spine surgery in the U.S. with a true minimally invasive approach designed to achieve reproducible, superior patient outcomes," said Trent Northcutt, President and Chief Executive Officer. "We are eager to introduce the ZIP across the U.K., and to drive the shift toward minimally invasive techniques. Our initial reception in the UK has been fantastic, and we want to thank Mr. James for his support of the Aurora vision."